BIOENGINEER

The Methylation Test That Decides Brain Cancer Treatment Faces a Reckoning

A new Mayo Clinic review in the Journal of Neuro-Oncology examines how MGMT promoter methylation guides brain tumor treatment ...
Newswise

Children’s Hospital Los Angeles’ Pioneering Liquid Biopsy Helps Guide Avery’s Treatment for Aggressive Brain Cancer

Children’s Hospital Los Angeles used its first-in-the-nation liquid biopsy test to closely monitor Avery’s treatment for an ...
Hosted on MSN

Breakthrough brain cancer test cuts diagnosis from weeks to hours: 'Huge leap forward for patients'

A breakthrough brain cancer test can give patients a diagnosis in less than two hours – slashing the agonising wait for answers and allowing treatment to begin sooner. The NHS is piloting the rapid ...
BIOENGINEER

Bioprinted Blood–Brain–Tumor Barrier Spheroids Put a ROS-Producing Ruthenium Drug to the Test Against Glioblastoma

Researchers built a 3D bioprinted blood–brain–tumor barrier spheroid that self-organizes into barrier and tumor layers and ...
Medical Xpress

Blood test detects aggressive brain tumors early and could reduce need for risky surgery

Researchers at the University of Sussex, in collaboration with scientists from different institutes worldwide, have identified a blood test capable of early diagnosis of the most aggressive form of ...

Ask Mayo Clinic: Doctors explain what to expect when cancer spreads to the brain

Treatment planning often involves specialists from neurosurgery, medical oncology, radiation oncology and other areas.